Crowe J P, Wilkinson S P, Bate C M, Willoughby C P, Peers E M, Richardson P D
Mater Misericordiae Hospital, Dublin, Eire.
Aliment Pharmacol Ther. 1989 Feb;3(1):83-91. doi: 10.1111/j.1365-2036.1989.tb00193.x.
In a double-blind parallel-group study, 98 patients with symptomatic duodenal ulcer received omeprazole 20 mg o.m. and 91 cimetidine 800 mg nocte for 2 or, if then not healed, 4 weeks. After 2 weeks the healing rates on an intention-to-treat basis were: for omeprazole 62% and for cimetidine 33% (P less than 0.001), and at 4 weeks 85% and 61%, respectively (P less than 0.001). The proportions symptom-free at 2 weeks were 83% of the omeprazole and 63% of the cimetidine-group (P less than 0.01) and at 4 weeks 84% and 72% (P = 0.01). Patients receiving omeprazole took fewer antacid tablets than those receiving cimetidine. Patient tolerance of both drugs was similar and good. In the treatment of duodenal ulcer, omeprazole 20 mg o.m. gives faster symptom relief than cimetidine 800 mg nocte, as well as healing a greater proportion of ulcers within 2 and 4 weeks.
在一项双盲平行组研究中,98例有症状的十二指肠溃疡患者口服奥美拉唑20毫克,91例患者每晚口服西咪替丁800毫克,疗程为2周,若未愈合则为4周。2周后,基于意向性治疗的愈合率分别为:奥美拉唑组62%,西咪替丁组33%(P<0.001);4周时,分别为85%和61%(P<0.001)。2周时无症状的比例,奥美拉唑组为83%,西咪替丁组为63%(P<0.01);4周时,分别为84%和72%(P=0.01)。接受奥美拉唑治疗的患者服用抗酸剂片的数量少于接受西咪替丁治疗的患者。两种药物的患者耐受性相似且良好。在十二指肠溃疡的治疗中,口服奥美拉唑20毫克比每晚口服西咪替丁800毫克能更快缓解症状,并且在2周和4周内愈合的溃疡比例更高。